Patenting biotech in Australia — an update
02 June, 2017 by Malcolm Lyons, Patent AttorneyObtaining a patent for a biotech invention is crucial to its further development and eventual commercialisation. Whether it's a new drug, insecticide or diagnostic, the developer needs to know they will have exclusive ownership of the invention and enjoy a return on their usually significant investment when they take the invention to the market.
Nominations open for AusBiotech and Johnson & Johnson Industry Excellence Awards
31 May, 2017Nominations have opened for the AusBiotech and Johnson & Johnson Industry Excellence Awards, to be presented at AusBiotech 2017 on 25 October.
Blocking the stress hormone: Phase II Alzheimer's trial underway
23 May, 2017Actinogen Medical has recruited and treated the first patient as part of its Phase II clinical trial of Xanamem, the biotech company's cortisol-blocking drug.
Hall of Fame award for IDT Australia
10 May, 2017Pharmaceutical manufacturing and drug development company IDT Australia has received a Victorian Manufacturing Hall of Fame award in the High Growth Sector of Medical Technologies and Pharmaceuticals.
Spinout company Exopharm to harness the regenerative power of exosomes
09 May, 2017Altnia Group has spun out a new company called Exopharm as part of its efforts to bring a new type of nanodrug called exosomes into local clinical trials.
Medicinal cannabis imported into Australia
02 May, 2017Health House International has successfully imported its first medicinal cannabis products into Australia, having received a federal import licence from the Australian Government earlier this year.
Therapeutic peptides from scorpion venom
28 April, 2017PreveCeutical Medical Inc (PMI) has signed a research and option agreement with UniQuest, the commercialisation company of The University of Queensland, to develop stabilised natural and synthetic peptides from scorpion venom.
Light-activated drugs for pain treatment
24 April, 2017European scientists have designed what is claimed to be the first light-activated drug for the treatment of pain, making a major step for the discipline of optopharmacology (the use of light to control drug activity).
Wearable sweat sensor diagnoses cystic fibrosis
20 April, 2017US researchers have developed a wristband-type sweat sensor that could transform diagnostics and drug evaluation for cystic fibrosis (CF), diabetes and other diseases.
OMNIlife science and Global Orthopaedic Technology sign licensing deal
10 April, 2017OMNIlife science and Global Orthopaedic Technology have signed an exclusive licensing agreement for OMNI's APEX Knee Implants for Australia, New Zealand and South Africa.
Funding boost for two medical device companies
10 April, 2017Two Australian medical companies have received government funding to fast-track commercialisation.
Australia urged to join the growing MTP sector
06 April, 2017According to a new report by CSIRO, medical technologies and pharmaceuticals (MTP) could add billions of dollars and thousands of jobs to the Australian economy within the next eight years.
Anti-inflammatory drug could slow motor neuron disease
29 March, 2017Researchers have shown that the anti-inflammatory drug PMX205 is effective in animals with amyotrophic lateral sclerosis (ALS), in a breakthrough which could see the drug taken to human trials as early as 2019.
How to heal a broken heart
28 March, 2017 by Lauren DavisUS scientists have identified a drug candidate to restore heart muscle function following a heart attack, in a breakthrough which has been described as a game changer for people living with heart disease.
What's my age again?
24 March, 2017 by Adam FloranceResearchers are just six months away from human trials of a new drug that appears to repair damaged DNA, reversing the effects of radiation and ageing.
